Isomark company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Debt | Alive

Total Raised


Last Raised

$580K | 9 mos ago

About Isomark

Isomark is a biotech company that develops technologies and products to aid in the rapid and early detection of various disease states including bacterial and viral infections, HIV, liver disease, and cancer. Isomark's patented technology is being developed to monitor exhaled breath to detect infections caused by viral, bacterial, and fungal sources soon after onset, along with a patient's response to antimicrobial treatment.

Isomark Headquarter Location

5930 Seminole Centre Court Suite F

Madison, Wisconsin, 53711,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Isomark

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Isomark is included in 2 Expert Collections, including Health Monitoring & Diagnostics.


Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Latest Isomark News

Check out the 10 diagnostics startups competing in the Pitch Perfect contest at MedCity INVEST

Apr 23, 2018

Check out the 10 diagnostics startups competing in the Pitch Perfect contest at MedCity INVEST Shares2 Investment in the healthcare diagnostics industry has been building momentum and the sector has enjoyed almost nonstop funding increases since 2009. In the first half of 2017 alone, funding approached $2.5 billion . Companies in clinical diagnostics include in vitro diagnostics (IVDs) and laboratory-developed tests. The interest in diagnostics companies is driven, in part, by the potential for these tests to support precision medicine and to detect life-threatening conditions earlier. At the MedCity INVEST conference in Chicago May 1-2, several diagnostics entrepreneurs will take the stage as part of the Pitch Perfect startup contest. Here’s a preview: —ADVERTISEMENT— DermaSensor  is working on a low-cost, handheld device to help healthcare professionals and patients assess skin cancer using patented spectroscopy and machine learning technology to evaluate skin lesions. Immortagen  is a cancer diagnostics company that combines proprietary tumor processing with artificial intelligence to identify true driver mutations in each patient’s tumor. Ischemia Care / Ischemic Stroke Lab Ischemia Care commercializes blood tests for the cause of strokes, including atrial fibrillation, across the stroke care continuum, including point of care. This year, Ischemia Care launched its first test, ISCDX, through its business Ischemic Stroke Lab. Isomark developed a non-invasive and rapid infection detection and monitoring tool using exhaled breath. In clinical studies, Isomark confirmed infections three days before standard methods and tracked a patient’s individualized response to treatment in near-real time. Mydimed produces algorithms and software tools that help prevent adverse drug reactions among high-risk patients. Attend  MedCity INVEST  to hear from healthcare innovators like Isomark, Onculogica, and others. Use promo code MCN50 to save $50. Register now . NoMo Diagnostics is working on real-time concussion detection for athletes and military personnel. Its technology uses a miniaturized quantitative electroencephalogram with a novel biosensor. Oculogica , a neurodiagnostic company founded by neurosurgeon Dr. Uzma Samadani, produced a < 4 minute, non-invasive, baseline-free concussion diagnostic with a simultaneous assessment of elevated intracranial pressure. Prenosis  has devised a way to predict the risk of infection-related adverse events for individual patients in real time. The system combines real-time data inputs from electronic medical records with relevant blood biomarker data measured either in a clinical lab or using a handheld point of care device. UE LifeSciences developed a point-of-care breast health examination device for health workers to use to detect breast lumps early without pain or radiation. Voyant Diagnostics  has an automated point-of-care urine diagnostic platform with the goal of integrating pregnancy screening in emergency departments, impacting care for all women of childbearing age. Image: AdrianHillman, Getty Images Join us for MedCity INVEST May 1-2, 2018, the premier national healthcare investing conference. INVEST unites over 300 active investors with corporate business development executives to facilitate investment opportunities with the most promising healthcare startups. Register now » Shares2

Isomark Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Isomark Rank

  • Where is Isomark's headquarters?

    Isomark's headquarters is located at 5930 Seminole Centre Court, Madison.

  • What is Isomark's latest funding round?

    Isomark's latest funding round is Debt.

  • How much did Isomark raise?

    Isomark raised a total of $990K.

  • Who are Isomark's competitors?

    Competitors of Isomark include MyAnIML.

You May Also Like

EIO Diagnostics

EIO Diagnostics creates health management tools for dairy animals. The company's technology of hyper-spectral imaging helps to detect infections early.

Cainthus Logo

Cainthus is an Irish startup focused on using computer vision and predictive imaging analysis to monitor the health and well-being of livestock.


MyAnIML develops disease prediction and tracking system using AI and blockchain to help the beef and dairy industry.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.